Progression of lupus nephritis during treatment with mycophenolate mofetil

Annals of the Rheumatic Diseases

Volumn 63, Issue 9, 2004, Pages 1179-1180

  Ahmadi Simab, K ^a   Lamprecht, P ^a   Gross, W L ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOPHOSPHAMIDE; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

AGED; ARTICLE; CASE REPORT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DRUG EFFICACY; DRUG PULSE THERAPY; DRUG WITHDRAWAL; HUMAN; KIDNEY BIOPSY; KIDNEY FUNCTION; LUPUS ERYTHEMATOSUS NEPHRITIS; PRIORITY JOURNAL; PROTEIN URINE LEVEL; PROTEINURIA; SIDE EFFECT; SYSTEMIC LUPUS ERYTHEMATOSUS;

DISEASE PROGRESSION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS NEPHRITIS; MIDDLE AGED; MYCOPHENOLIC ACID; TREATMENT FAILURE;

EID: 4344631917     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.016600     Document Type: Article

References (4)

1. Austin HA 3rd, Klippel JH, Balow JE, le Riche NG, Steinberg AD, Plotz PH, et al. herapy of lupus nephritis. Controlled trial of prednisone and cytotoxic drugs. N Engl J Med 1986;314:614-19.
2. Boumpas DT, Austin HA 3rd, Vaughn EM, Klippel JH, Steinberg AD, Yarboro CH, et al. ontrolled trial of pulse methylprednisolone versus two regimens of pulse cyclophosphamide in severe lupus nephritis. Lancet 1992;340:741-5.
3. Chan TM, Li FK, Tang CS, Wong RW, Fang GX, Ji YL, et al. Efficacy of mycophenolate mofetil in patients with diffuse proliferative lupus nephritis. N Engl J Med 2000;343:1156-62.
4. Gescuk BD, Davis JC. Novel therapeutic agents for systemic lupus erythematosus. Curr Opin Rheumatol 2002;14:515-21.